# NAD+ for heart failure: randomized trial of IV infusions

Source: https://pepvault.app/research/nad-yu-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [NAD+](https://pepvault.app/research#nad)

Randomized trial · people

# NAD+ improved LVEF at 1 month in ischemic heart failure

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

A short course of IV NAD+ added to standard care gave a modest LVEF gain at 1 month in ischemic heart failure, while effects on hospital stays and symptoms remain unconfirmed.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 180
- **Published:** 2026
- **Journal:** Am J Cardiovasc Drugs

## What they tested

The team tested whether NAD+ given into a vein improves heart function and clinical outcomes in people with heart failure caused by ischemic cardiomyopathy, heart muscle damage from poor blood flow.

## How the study was done

A single-center, randomized, placebo-controlled trial in 180 adults with ischemic cardiomyopathy, an LVEF (the share of blood the heart pumps out with each beat) of 45% or less, and NYHA class II-III symptoms (mild to marked limits on activity). Patients got either IV NAD+ at 10 mg/day or a placebo drip (5% glucose/normal saline) for 7 days on top of standard heart failure medicines, with follow-up to 6 months.

<!--promo-->

PepVault for iPhone

## Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At 1 month, LVEF improved more in the NAD+ group than in the placebo group (45.44% vs 42.44%, p = 0.024), the trial's main result. NT-proBNP, a blood marker of heart strain, was lower with NAD+ at day 7 (1471.00 vs 2317.50 pg/mL), but this did not reach statistical significance (p = 0.102). Major heart and brain events over 6 months were 14.6% with NAD+ vs 24.7% with placebo (p = 0.089), mostly from fewer first unplanned heart failure hospital stays (13.5% vs 23.6%, p = 0.078). Better NYHA class was more common with NAD+ at 1 month (73.0% vs 57.3%) and 6 months (53.9% vs 39.3%), but these differences were not statistically significant, and heart size measures did not change differently between groups.

## What it doesn’t show

This was a small, single-center trial with only 7 days of treatment, and only the LVEF change reached statistical significance; the gaps in hospital stays, events and symptoms could be chance. It looked only at people with heart failure from ischemic cardiomyopathy getting IV NAD+, not other forms of heart failure or other ways of taking NAD+.

## The paper

Yu et al. Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial. Am J Cardiovasc Drugs. 2026.

- [PubMed (PMID 40954388)](https://pubmed.ncbi.nlm.nih.gov/40954388/)
- [The paper (DOI 10.1007/s40256-025-00764-7)](https://doi.org/10.1007/s40256-025-00764-7)

## The compound

- [NAD+: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)

## With this study

### NAD+

- [NAD+: the full reference](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)

### Mixing charts

- [100 mg vial](https://pepvault.app/tools/reconstitution-calculator/nad-100mg)
- [500 mg vial](https://pepvault.app/tools/reconstitution-calculator/nad-500mg)
- [1000 mg vial](https://pepvault.app/tools/reconstitution-calculator/nad-1000mg)

### Studies

- [NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 days](https://pepvault.app/research/nad-christen-2026)
- [NMN raised serum nicotinamide over 12 weeks in middle-aged adults](https://pepvault.app/research/nad-katayoshi-2023)
- [All 7 studies](https://pepvault.app/research#nad)

### Compared with

- [NAD+ vs NMN](https://pepvault.app/peptides/compare/nad-vs-nmn)
- [NAD+ vs Glutathione](https://pepvault.app/peptides/compare/nad-vs-glutathione)
- [NAD+ vs MOTS-c](https://pepvault.app/peptides/compare/nad-vs-mots-c)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## More studies on NAD+

- [NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 days](https://pepvault.app/research/nad-christen-2026) Randomized trial · people · 2026
- [NMN raised serum nicotinamide over 12 weeks in middle-aged adults](https://pepvault.app/research/nad-katayoshi-2023) Randomized trial · people · 2023
- [NMN (MIB-626) raised blood NAD levels in older adults over 14 days](https://pepvault.app/research/nad-pencina-2023) Randomized trial · people · 2023
- [NMN supplements raised blood NAD+ levels in healthy older men](https://pepvault.app/research/nmn-igarashi-2022) Randomized trial · people · 2022
- [NMN raised muscle insulin sensitivity in women with prediabetes](https://pepvault.app/research/nad-yoshino-2021) Randomized trial · people · 2021
- [NAD+ rose with nicotinamide riboside in a 6-week crossover trial](https://pepvault.app/research/nad-martens-2018) Randomized trial · people · 2018
- [Every study on NAD+](https://pepvault.app/research#nad)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### NAD+

- [NAD+: the full reference](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)

### Mixing charts

- [100 mg vial](https://pepvault.app/tools/reconstitution-calculator/nad-100mg)
- [500 mg vial](https://pepvault.app/tools/reconstitution-calculator/nad-500mg)
- [1000 mg vial](https://pepvault.app/tools/reconstitution-calculator/nad-1000mg)

### Studies

- [NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 days](https://pepvault.app/research/nad-christen-2026)
- [NMN raised serum nicotinamide over 12 weeks in middle-aged adults](https://pepvault.app/research/nad-katayoshi-2023)
- [All 7 studies](https://pepvault.app/research#nad)

### Compared with

- [NAD+ vs NMN](https://pepvault.app/peptides/compare/nad-vs-nmn)
- [NAD+ vs Glutathione](https://pepvault.app/peptides/compare/nad-vs-glutathione)
- [NAD+ vs MOTS-c](https://pepvault.app/peptides/compare/nad-vs-mots-c)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on NAD+](https://pepvault.app/research#nad)

## The library

- [NAD+](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
